# Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation

> **NCT00461825** · PHASE3 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 207 (—)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Cyclosporin A: C0: 75-125ng/ml-dose adapted in the 3 groups
- **DRUG:** Group A: CsA + Azathioprine(1 to 2 mg/kg/day)
- **DRUG:** Group B: CsA + CellCept(500 mg x 2/day)
- **DRUG:** Group C: CsAm

## Key facts

- **NCT ID:** NCT00461825
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 207 (—)
- **Last updated:** 2007-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461825, "Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00461825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*